New to Meducation?
Sign up
Already signed up? Log In
view moderators

PharmaceuticalPreparations

Category

Www.bmj
1
3

Drug development is at risk from proposed takeover of AstraZeneca, MPs are told

Development of important and potentially lifesaving drugs could be disrupted and delayed if a proposed takeover of AstraZeneca by the giant US drug company Pfizer goes ahead, MPs have been told.  
bmj.com
over 7 years ago
Www.bmj
1
4

US citizens are living longer and consuming more prescription drugs than ever, finds report

People in the United States are living longer and are consuming more prescription drugs than ever before, an annual report on the nation’s health prepared by the Centers for Disease Control and Prevention has found.1  
bmj.com
over 7 years ago
Preview
3
464

Learn: Antidepressant, Antipsychotic, Antianxiety Drugs (by lekhoa) - Memorize.com - Remember and Understand

Learn Antidepressant, Antipsychotic, Antianxiety Drugs facts using a simple interactive process (flashcard, matching, or multiple choice). Finally a format that helps you memorize and understand. Browse or search in thousands of pages or create your own page using a simple wizard. No signup required!  
memorize.com
over 7 years ago
Drug injury attorney 300x215
1
3

Defective Pharmaceutical Drugs and Unsafe Drugs Side Effects Lawsuit Lawyer

Serious side effects may result from defective pharmaceutical drugs and unsafe drugs. If you have been harmed by a defective drug, our attorneys can help.  
downtownlalaw.com
over 7 years ago
Preview
1
65

PROSTAGLANDINS, TRIGLYCERIDES & PHOSPHOLIPIDS by Professor Fink

Review of Biological Chemistry, including Prostaglandins, Triglycerides & Phospholipids. Reference is made to inflammation, anti-inflammatory drugs, monoglyc...  
YouTube
over 7 years ago
Preview
7
380

Renin-Angiotensin-Aldosterone System (The RAAS)

All about the RAAS - what it is, how it works and even how to understand all those complicated inhibitory drugs! The RAAS is an extremely important endocrine...  
YouTube
over 7 years ago
Www.bmj
1
86

Management and prevention of exacerbations of COPD

Patients with chronic obstructive pulmonary disease (COPD) are prone to acute respiratory exacerbations, which can develop suddenly or subacutely over the course of several days. Exacerbations have a detrimental effect on patients’ health status and increase the burden on the healthcare system. Initial treatment is unsuccessful in 24-27% of patients, who have a relapse or a second exacerbation within 30 days of the initial event. No obvious benefit has been seen in recent clinical trials of anti-tumour necrosis factor therapy, anti-leukotriene therapy, intensive chest physiotherapy, or early inpatient pulmonary rehabilitation for treatment of exacerbations. By contrast, clinical trials of prevention rather than acute treatment have shown promising results. Long acting β agonist (LABA) or long acting anti-muscarinic (LAMA) bronchodilators and inhaled corticosteroid-LABA combinations prevent exacerbations in patients at risk, with relative risk reductions averaging 14-27% for each of these drugs relative to placebo. Triple therapy with inhaled corticosteroid-LABA plus LAMA may provide additional benefit, although study results to date are heterogeneous and more studies are needed. Pneumonia is an important complication of treatment with inhaled corticosteroid-LABA products, and the risk of pneumonia seems to be doubled in patients with COPD who use fluticasone. The addition of azithromycin to usual COPD therapy prevents exacerbations, although it may prolong the Q-T interval and increase the risk of death from cardiovascular disease in patients prone to arrhythmia. New potential drugs—including mitogen activated protein kinase inhibitors, phosphodiesterase 3 inhibitors, and monoclonal antibodies to the interleukin 1 receptor—offer additional hope for treatments that may prevent exacerbations in the future.  
bmj.com
over 7 years ago
Www.bmj
1
27

Do the solutions for global health lie in healthcare?

Jocalyn Clark argues that the medicalisation of global health, like other aspects of human life and health, produces a narrow view of global health problems and will limit the success of solutions proposed to replace the millennium development goals  
bmj.com
over 7 years ago
Preview
1
18

Sarah Boseley asks if the latest guidelines on drugs for MS sufferers are good news or bad

Sarah Boseley asks if the latest guidelines on drugs for MS sufferers are good news or bad  
the Guardian
over 7 years ago
Preview
1
88

Pharmacokinetics 4 - Metabolism

http://www.handwrittentutorials.com - This tutorial is the fourth in the Pharmacokinetics series. This tutorial discusses how drugs are metabolised by Cytoch...  
YouTube
over 7 years ago
Preview
1
58

110 Hypertension Treatment

http://www.interactive-biology.com - What are the mechanisms that underly the drugs that are used to treat hypertension? Drugs like ACE inhibitors, diuretics...  
YouTube
over 7 years ago